Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Advanced Breast Cancer
Related studies linked through entity extraction aliases.
A Phase I/II Study of XZP-3287 in Metastasis Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
RCT of CBD for Anxiety in Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Locoregional Surgery of the Primary Tumor in de Novo Stage IV Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- N/A
Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease
- Status
- COMPLETED
- Phase
- PHASE2
First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBC
- Status
- COMPLETED
- Phase
- PHASE2
Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)
- Status
- TERMINATED
- Phase
- PHASE2
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase I Study of LX-039 Tablets
- Status
- COMPLETED
- Phase
- PHASE1
Implementing Patients´ Competence in Oral Breast Cancer Therapy
- Status
- UNKNOWN
- Phase
- N/A
A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Olaparib+Trastuzumab in HER2[+],Breast Cancer Susceptibility Gene (BRCA) Mutated Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Safety and Pharmacokinetics of ODM-209
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2